Søren Morgenthaler Echwald

Chief Executive Officer at Anapa Biotech A/S

Commercial Services

Profile

Søren Morgenthaler Echwald is currently the Chief Executive Officer at Anapa Biotech A and a Director at Ranger Biotechnologies A.
He was previously the Vice President-Business Development at Exiqon A.

Søren Morgenthaler Echwald active positions

Companies	Position	Start
Anapa Biotech A/S Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark.	Chief Executive Officer	-
Ranger Biotechnologies A/S Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark.	Director/Board Member	-

All active positions of Søren Morgenthaler Echwald

Former positions of Søren Morgenthaler Echwald

Companies	Position	End
EXIQON A/S	Corporate Officer/Principal	-

See the detail of Søren Morgenthaler Echwald's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Søren Morgenthaler Echwald's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Exiqon A/S Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Exiqon A/S engages in the development of solutions for ribonucleic acid research and analysis through its Locked Nucleic Acid proprietary technology. Its products and services are used by researchers in academia, biotech, and pharmaceutical companies around the world to make discoveries about the correlation between gene activity and the development of disease. The company was founded by Mikael Ørum, Henrik Ørum and Troels Koch on November 1, 1995 and is headquartered in Copenhagen, Denmark.	Commercial Services
Anapa Biotech A/S Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark.	Commercial Services
Ranger Biotechnologies A/S Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark.	Commercial Services

See company connections